About Astellas Pharma, Inc. 
Astellas Pharma, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
524,320 Million
(Quarterly Results - Sep 2025)
Net Profit:
79,213 Million
Pharmaceuticals & Biotechnology
JPY 4,060,884 Million (Large Cap)
50.00
NA
0.00%
0.28
7.74%
2.52






